Oncology
Charity commits £800,000 to AI research into late breast cancer recurrence
October 28, 2026AI, Immunology, Oncology, breast cancer, cytology, oncology, research and development
Breast Cancer Now is investing £800,000 in two research projects using artificial intelligence to investigate why oestrogen receptor-positive (ER-positive) breast …
Most advanced breast cancer patients treated in community settings, Phesi study finds
October 26, 2026Oncology, breast cancer, clinical trials, community healthcare, oncology
Most patients with advanced hormone receptor-positive, HER2-negative (HR+/HER2-) breast cancer are treated in community settings rather than academic centres, potentially …
Amphista doses first patient in AML trial of protein degrader
October 20, 2026AML, FDA, Oncology, clinical trial, drug development, pharma
Amphista Therapeutics has dosed the first patient in a phase 1 trial of AMX-883, an experimental oral therapy targeting acute …
Sterling doubles ADC manufacturing capacity at Welsh facility
October 16, 2026ADCs, Corporate, HPLC, Immunology, Infections and infestations, Oncology, manufacturing
Sterling Pharma Solutions has completed a multi-million-pound expansion of its dedicated bioconjugation facility in Deeside, Wales, doubling manufacturing capacity and …
Femtosecond laser cuts lung tumour margin assessment time
October 15, 2026Devices, Diagnostics, Hospital Management, Oncology, laser imaging, lung disease, tumour
Femtosecond laser imaging has reduced the time needed to assess lung tumour margins from 36 minutes to less than six …
Fortysomethings’ non-attendance at NHS Health Checks raises concerns, says study
October 11, 2026Chronic Diseases, NHS, Oncology, cardiovascular disease, survey
People in their forties account for almost three-quarters of those who do not attend NHS Health Checks, highlighting the challenge …
NICE recommends daratumumab quadruplet for newly diagnosed multiple myeloma
October 8, 2026NICE, Oncology, drug recommendation, drug regulation
NICE has published final draft guidance recommending daratumumab with bortezomib, lenalidomide and dexamethasone (D-VRd) for previously untreated adults with multiple …
From lab breakthrough to NHS treatment: Getting innovative therapies to patients
September 5, 2026Clinical trials supplies & documentation logistics, Due Diligence, NICE / SMC Submissions, Pharmacovigilance, Regulatory Affairs Oncology
By Chloe Williams and Sarah Ellson Innovative therapies are transforming the treatment landscape for serious diseases, particularly cancer. Advances in …
Japan approve Daiichi Sankyo’s Enhertu as a second-line treatment for gastric cancer
April 9, 2026Oncology
The Japan Pharmaceuticals and Medical Devices Agency (PMDA) has accepted the updated prescribing information for Daiichi Sankyo’s Enhertu (trastuzumab), a …
Outrun Therapeutics announces its lead programme for HPV positive cancer
March 23, 2026Research and Development HPV, Oncology, Outrun Therapeutics
Outrun Therapeutics has selected an E6AP inhibitor strategy as its lead programme for treating HPV positive head and neck cancer. …
Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine
February 11, 2026Research and Development Infinitopes, Oncology
Infinitopes, a clinical stage biotechnology company specialising in oncology, has announced the receipt of an additional $15.4m in seed funding, …
QV Bioelectronics secures £4.5m in funding for brain cancer therapy development
February 3, 2026Research and Development Oncology, QV Bioelectronics, glioblastoma
QV Bioelectronics, a medtech business specialising in implants for cancer treatment, has announced that it has received £4.5m in funding …
Pierre Fabre Laboratories and Iktos announce oncology collaboration
January 21, 2026Research and Development Iktos, Oncology, Pierre Fabre Laboratories
Pierre Fabre Laboratories and Iktos have announced a new collaboration intended to discover and develop new small-molecule drug candidates for …
Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project
January 14, 2026Research and Development Bio-Sourcing, Oncology, Zerion Pharma, breast cancer
Bio-Sourcing and Zerion Pharma have announced that their collaboration to develop an oral form of the monoclonal antibody trastuzumab for …
Biocartis announces breast cancer research collaboration with US Mayo Clinic
January 14, 2026Research and Development Biocartis, Mayo Clinic, Oncology, breast cancer
Biocartis has announced a research collaboration with Mayo Clinic in the US, aiming to develop an accelerated sample-to-answer test resulting …
Latest content
Acumetis CEO Herspiegel steps down as Burden assumes role
